Lactose (India)

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE058I01013
NSEID:
BSEID: 524202
View on BSE

INR

84.98

-1.13 (-1.31%)

BSENSE

Mar 23

BSE+NSE Vol: 5.15 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Smruthi Organic

Parnax Lab

Balaxi Pharma

Bal Pharma

Lactose (India)

Tyche Industries

Alpa Laboratorie

Pharmaids Pharma

Sotac Pharma.

Krebs Biochem

Guj. Inject(Ker)

Why is Lactose (India) Ltd ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.74%

Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.54 times

Flat results in Dec 25

PAT(Q) At Rs 0.53 cr has Fallen at -53.1% (vs previous 4Q average)
INTEREST(Q) At Rs 1.39 cr has Grown at 33.65%

26.07% of Promoter Shares are Pledged

In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices

Underperformed the market in the last 1 year

Even though the market (BSE500) generated negative returns of -3.31% in the last 1 year, its fall in the stock was much higher with a return of -15.90%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lactose (India) for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Lactose (India)

-15.9%

-0.34

47.26%

Sensex

-5.47%

-0.43

12.65%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

33.05%

EBIT Growth (5y)

57.49%

EBIT to Interest (avg)

1.81

Debt to EBITDA (avg)

3.64

Net Debt to Equity (avg)

0.88

Sales to Capital Employed (avg)

0.83

Tax Ratio

29.74%

Dividend Payout Ratio

Pledged Shares

26.07%

Institutional Holding

0.62%

ROCE (avg)

9.93%

ROE (avg)

6.65%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.82

EV to EBIT

15.04

EV to EBITDA

9.81

EV to Capital Employed

1.44

EV to Sales

1.09

PEG Ratio

Dividend Yield

ROCE (Latest)

10.45%

ROE (Latest)

8.22%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET SALES(Latest six months)

At Rs 77.95 cr has Grown at 31.74%

-5What is not working for the Company

PAT(Q)

At Rs 0.53 cr has Fallen at -53.1% (vs previous 4Q average

INTEREST(Q)

At Rs 1.39 cr has Grown at 33.65%

Loading Valuation Snapshot...

Here's what is working for Lactose (India)

Net Sales - Latest six months

At Rs 77.95 cr has Grown at 31.74%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Lactose (India)

Profit After Tax (PAT) - Quarterly

At Rs 0.53 cr has Fallen at -53.1% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 1.13 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Interest - Quarterly

At Rs 1.39 cr has Grown at 33.65%

Quarter on Quarter (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)